Frontier Medicines
1 known investors
Frontier Meds develops small-molecule drugs targeting previously undruggable protein targets using a proprietary approach to identify and exploit novel binding sites across the human proteome.
Biotech
Investors · 1
In the news
- Frontier Medicines Announces Oversubscribed $80 Million Series C Financing to Support Progress of Clinical-Stage Pipeline | Frontier Medicinesfrontiermeds.com · 2025
- Frontier Medicines Raises $80M in Series C Funding | Precision Medicine Onlineprecisionmedicineonline.com · 2024
- Frontier Medicines Raises $80M in Series C, Targets Amgen and BMS in KRAS - BioSpacebiospace.com · 2024
- Frontier CEO weathers 'hardest financing' ever to raise $80Mfiercebiotech.com · 2024
- Frontier Medicines Raises $88.5 Million to Advance Chemoproteomics Program - BioSpacebiospace.com · 2021
- Frontier Medicines Raises $88.5 Million Series B Financing to Advance Precision Oncology and Targeted Protein Degradation Pipelineglobenewswire.com · 2021